 |
Video: What is a Stock Split?
|
 |
| Dynavax Technologies Corporation is a commercial-stage biopharmaceutical company, which is engaged in developing and commercializing vaccines. Co.'s products include HEPLISAV-B hepatitis B vaccine and CpG 1018. Its HEPLISAV-B ((Recombinant)(Adjuvanted) is indicated for the prevention of infection caused by all known subtypes of the hepatitis B virus in adults 18 years of age and older. HEPLISAV-B is a two-dose hepatitis B vaccine for adults. It also manufactures and sells CpG 1018 adjuvant, the adjuvant used in HEPLISAV-B. It is also engaged in developing a multi-program clinical pipeline leveraging CpG 1018 adjuvant to develop improved vaccines for indications with unmet medical needs. According to our DVAX split history records, DVAX has had 1 split. | |
 |

DVAX (DVAX) has 1 split in our DVAX split history database. The split for DVAX took place on November 10, 2014. This was a 1 for 10 reverse split, meaning for each 10 shares of DVAX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.
When a company such as DVAX conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the DVAX split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into DVAX shares, starting with a $10,000 purchase of DVAX, presented on a split-history-adjusted basis factoring in the complete DVAX split history.

Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
09/12/2016 |
|
| End date: |
02/10/2026 |
|
| Start price/share: |
$12.19 |
|
| End price/share: |
$15.50 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
27.15% |
|
| Average Annual Total Return: |
2.58% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$12,711.64 |
|
| Years: |
9.42 |
|
|
 |
| Date |
Ratio |
| 11/10/2014 | 1 for 10 |
|
 |